Thermo Fisher Scientific Inc (TMO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Thermo Fisher Scientific Inc (TMO) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.24 Billion) by net assets ($51.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TMO net asset quality score to measure how much of total assets are equity-financed.
Thermo Fisher Scientific Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Thermo Fisher Scientific Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Thermo Fisher Scientific Inc to evaluate the quality of earnings relative to operating cash generation.
Thermo Fisher Scientific Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Thermo Fisher Scientific Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Novartis AG
SW:NOVN
|
0.092x |
|
BHP Group Ltd
AU:BHP
|
0.172x |
|
Arm Holdings plc American Depositary Shares
NASDAQ:ARM
|
0.031x |
|
Nestlé S.A
F:NESM
|
0.137x |
|
American Express Company
NYSE:AXP
|
0.112x |
|
Citigroup Inc.
NYSE:C
|
-0.103x |
|
Nestle S.A.
SW:NESN
|
0.334x |
|
Bank of China Limited
SHG:601988
|
0.060x |
Annual Cash Flow Conversion Efficiency for Thermo Fisher Scientific Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Thermo Fisher Scientific Inc from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see TMO market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $49.67 Billion | $8.67 Billion | 0.174x | -2.77% |
| 2023-12-31 | $46.84 Billion | $8.41 Billion | 0.179x | -13.45% |
| 2022-12-31 | $44.15 Billion | $9.15 Billion | 0.207x | -10.97% |
| 2021-12-31 | $40.98 Billion | $9.54 Billion | 0.233x | -3.02% |
| 2020-12-31 | $34.52 Billion | $8.29 Billion | 0.240x | +43.30% |
| 2019-12-31 | $29.68 Billion | $4.97 Billion | 0.168x | +1.76% |
| 2018-12-31 | $27.59 Billion | $4.54 Billion | 0.165x | +4.50% |
| 2017-12-31 | $25.41 Billion | $4.00 Billion | 0.158x | +7.55% |
| 2016-12-31 | $21.54 Billion | $3.16 Billion | 0.147x | +11.06% |
| 2015-12-31 | $21.35 Billion | $2.82 Billion | 0.132x | +3.49% |
| 2014-12-31 | $20.55 Billion | $2.62 Billion | 0.127x | +6.87% |
| 2013-12-31 | $16.86 Billion | $2.01 Billion | 0.119x | -9.55% |
| 2012-12-31 | $15.46 Billion | $2.04 Billion | 0.132x | +17.28% |
| 2011-12-31 | $15.04 Billion | $1.69 Billion | 0.112x | +15.32% |
| 2010-12-31 | $15.36 Billion | $1.50 Billion | 0.098x | -9.32% |
| 2009-12-31 | $15.43 Billion | $1.66 Billion | 0.108x | +13.01% |
| 2008-12-31 | $14.93 Billion | $1.42 Billion | 0.095x | -7.08% |
| 2007-12-31 | $14.49 Billion | $1.48 Billion | 0.102x | +251.15% |
| 2006-12-31 | $13.91 Billion | $405.65 Million | 0.029x | -69.94% |
| 2005-12-31 | $2.79 Billion | $270.91 Million | 0.097x | -2.26% |
| 2004-12-31 | $2.67 Billion | $264.51 Million | 0.099x | +9.11% |
| 2003-12-31 | $2.38 Billion | $216.72 Million | 0.091x | +79.74% |
| 2002-12-31 | $2.03 Billion | $102.89 Million | 0.051x | -48.56% |
| 2001-12-31 | $1.92 Billion | $188.40 Million | 0.098x | +25.91% |
| 2000-12-31 | $2.56 Billion | $199.92 Million | 0.078x | -44.69% |
| 1999-12-31 | $2.39 Billion | $337.12 Million | 0.141x | +28.65% |
| 1998-12-31 | $2.99 Billion | $328.50 Million | 0.110x | +14.73% |
| 1997-12-31 | $2.81 Billion | $269.00 Million | 0.096x | +7.21% |
| 1996-12-31 | $2.52 Billion | $224.50 Million | 0.089x | -17.94% |
| 1995-12-31 | $1.79 Billion | $194.60 Million | 0.109x | -29.79% |
| 1994-12-31 | $1.32 Billion | $204.20 Million | 0.155x | +40.71% |
| 1993-12-31 | $1.15 Billion | $126.70 Million | 0.110x | +44.94% |
| 1992-12-31 | $722.70 Million | $54.90 Million | 0.076x | +101.14% |
| 1991-12-31 | $609.00 Million | $23.00 Million | 0.038x | -18.82% |
| 1990-12-31 | $399.80 Million | $18.60 Million | 0.047x | -74.37% |
| 1989-12-31 | $262.20 Million | $47.60 Million | 0.182x | -- |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines,… Read more